The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit
The non-negligible failure rate of NGS testing highlights the crucial need for implementing specific guidelines and Standard Operating Procedures for samples intended for NGS. With the use of a risk-based biopsy framework to guide clinical decisions, procedure-related complications may be minimized.
Authors
- Carmen Criscitiello (ORCID: https://orcid.org/0000-0001-9064-0113)
- Giuseppe Curigliano (ORCID: https://orcid.org/0000-0003-1781-2518)
- Liliana Ascione (ORCID: https://orcid.org/0000-0002-2807-7400)
- Carmen Belli (ORCID: https://orcid.org/0000-0001-7067-7496)
- Daniele Maiettini (ORCID: https://orcid.org/0000-0003-4421-7941)
- Franco Orsi (ORCID: https://orcid.org/0000-0002-7330-0499)
- Gianluca Maria Varano (ORCID: https://orcid.org/0000-0003-4505-5841)
- Elena Guerini‐Rocco (ORCID: https://orcid.org/0000-0003-2001-7582)
- Nicola Fusco (ORCID: https://orcid.org/0000-0002-9101-9131)
- Dario Trapani (ORCID: https://orcid.org/0000-0003-1672-9560)
- Edoardo Crimini (ORCID: https://orcid.org/0000-0002-1869-0607)
- Luca Boscolo Bielo (ORCID: https://orcid.org/0000-0003-1026-3923)
- R. Scalia
- Matteo Repetto (ORCID: https://orcid.org/0009-0002-4943-630X)
- Roberta Scafetta
- Paolo Della Vigna (ORCID: https://orcid.org/0000-0002-8523-9226)
- Antonio Marra (ORCID: https://orcid.org/0000-0002-7310-7824)
- Jalissa Katrini (ORCID: https://orcid.org/0009-0003-1405-0586)
- Grazia Castellano (ORCID: https://orcid.org/0000-0003-2147-1672)
- Angela Espósito
- Elisa Giordano
Institutions
- Università Campus Bio-Medico (IT)
- University of Milan (IT)
- European Institute of Oncology (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3390/cancers16244252
- Citations
- 4
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.14
Funders
- AstraZeneca
- European Society for Medical Oncology